Product
All Trans Retinoic Acid
2 clinical trials
2 indications
Indication
Colorectal CancerIndication
Drug EffectClinical trial
Phase II Single-arm, Single-center Clinical Trial of All-trans-retinoic Acid, Bevacizumab and Atezolizumab in Refractory Microsatellite Stable Colorectal CancerStatus: Recruiting, Estimated PCD: 2026-10-01
Clinical trial
Treatment With Nivolumab and All-trans Retinoic Acid for Patients With Refractory Pancreatic CancerStatus: Recruiting, Estimated PCD: 2025-02-28